Economic analysis of implementing Systemic Coronary Risk Estimation (SCORE2) scale and long-term consequences
Objective: to assess the demand for pharmacotherapy in risk groups on adverse cardiovascular (CV) events identified during prophylactic medical examination of the adult population according to the SCORE2 (Systemic Coronary Risk Estimation) scale, which is being introduced into clinical practice.Mate...
Saved in:
Main Authors: | E. O. Kurilovich, A. V. Nikitina, I. V. Sorokovikov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2024-11-01
|
Series: | Фармакоэкономика |
Subjects: | |
Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/1090 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Appointment of lipid-lowering therapy in the Russian population: comparison of SCORE and SCORE2 (according to the ESSE-RF study)
by: A. M. Erina, et al.
Published: (2022-06-01) -
DISEASE SEVERITY SCORING SYSTEMS IN EMERGENCY NEONATOLOGY. ADVANTAGES AND DISADVANTAGES OF SCALES
by: O. P. KOVTUN, et al.
Published: (2019-07-01) -
Comparability of cardiovascular risk assessment according to the SCORE and the coronary artery calcium score (Agatston score)
by: A. S. Safaryan, et al.
Published: (2023-11-01) -
Comparative assessment of cardiovascular risk in European and Korean ethnic groups in the Russian population using the SCORE and SCORE2
by: D. Yu. Bogdanov, et al.
Published: (2022-03-01) -
Clinical profile of pediatric traumatic brain injury, pediatric trauma score and its correlation with short-term outcomes: An experience from a tertiary care hospital in coastal Karnataka
by: Jason Glen I. Dsouza, et al.
Published: (2025-01-01)